ProShare Advisors
ANAB icon

ProShare Advisors’s AnaptysBio ANAB Stock Holding History

ProShare Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
3,544
-340
-9% -$20.6K ﹤0.01% 1543
2026
Q1 		$215K Sell
3,884
-714
-16% -$38.4K ﹤0.01% 1529
2025
Q4 		$223K Buy
+4,598
New +$179K ﹤0.01% 1647
2022
Q1 		– Sell
-8,085
Closed -$282K – 2205
2021
Q4 		$282K Sell
8,085
-246
-3% -$7.8K ﹤0.01% 1821
2021
Q3 		$226K Sell
8,331
-1,588
-16% -$40.3K ﹤0.01% 1730
2021
Q2 		$257K Buy
9,919
+412
+4% +$9.88K ﹤0.01% 1986
2021
Q1 		$205K Buy
+9,507
New +$240K ﹤0.01% 2025
2019
Q4 		– Sell
-10,120
Closed -$354K – 1792
2019
Q3 		$354K Sell
10,120
-4
-0% -$190 ﹤0.01% 1137
2019
Q2 		$571K Sell
10,124
-1,338
-12% -$96.3K ﹤0.01% 962
2019
Q1 		$837K Buy
11,462
+169
+1% +$11.7K 0.01% 839
2018
Q4 		$720K Sell
11,293
-832
-7% -$61.9K 0.01% 807
2018
Q3 		$1.21M Sell
12,125
-193
-2% -$16K 0.01% 747
2018
Q2 		$875K Sell
12,318
-827
-6% -$69.4K 0.01% 886
2018
Q1 		$1.37M Sell
13,145
-2,165
-14% -$244K 0.01% 718
2017
Q4 		$1.54M Buy
+15,310
New +$1.13M 0.01% 686

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

ProShare Advisors's ANAB Position: Q2 2026 in Review

ProShare Advisors reduced its AnaptysBio (ANAB) stake by 8.8% in Q2 2026, selling an estimated $20.6K and leaving 3,544 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

ProShare Advisors first reported a position in ANAB in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.54M in Q4 2017. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • ProShare Advisors held 3,544 shares of AnaptysBio worth $239K as of Q2 2026.
  • ProShare Advisors sold 340 AnaptysBio shares in Q2 2026, an estimated $20.6K.
  • AnaptysBio made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1543 holding.
  • ProShare Advisors first reported a position in AnaptysBio in Q4 2017 and has held it in 15 quarters since.
  • ProShare Advisors's AnaptysBio position peaked at $1.54M in Q4 2017.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.